Fibroblast Activation Protein Imaging, An Issue of PET Clinics

<p>Advanced Fibroblast Activation Protein-Ligand Developments: FAP Imaging Agents: A Review of the Structural Requirements</p> <p>Fibroblast Activation Protein Inhibitor PET in Pancreatic Cancer</p> <p>The Diagnostic Value of Fibroblast Activation Protein Imaging in Hepatocellular Carcinoma and Cholangiocellular Carcinoma</p> <p>Fibroblast Activation Protein Inhibitor PET Imaging in Head and Neck Cancer</p> <p>Fibroblast Activation Protein Inhibitor-PET Imaging in Colorectal Cancer</p> <p>Fibroblast Activation Protein Inhibitor PET/CT in Gastric Cancer</p> <p>Current Status of Fibroblast Activation Protein Imaging in Gynecologic Malignancy and Breast Cancer</p> <p>Fibroblast Activation Protein Inhibitor (FAPI)-PET Imaging in Sarcoma</p> <p>Fibroblast Activation Protein Inhibitor Theranostics: The Case for Use in Sarcoma</p> <p>Radiation Therapy Planning Using Fibroblast Activation Protein Inhibitor</p> <p>Imaging Fibrosis</p> <p>Cardiac Applications of Fibroblast Activation Protein Imaging</p> <p>Fibroblast Activation Protein Inhibitor Theranostics: Preclinical Considerations</p> <p>Fibroblast Activation Protein Inhibitor Theranostics: Preclinical Combination Treatment</p> <p>Fibroblast Activation Protein Inhibitor Theranostics: Early Clinical Translation</p> <p>Current State of Clinical Trials and Regulatory Approvals with Fibroblast Activation Protein Targeting Interventions</p>